Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam study

BACKGROUND: Fatty liver disease (FLD) is the most common cause of liver dysfunction in developed countries. There is great interest in developing clinically valid and minimally invasive biomarkers to enhance early diagnosis of FLD. AIM: To investigate the potential of circulatory microRNAs (miRNAs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiaofang, Mens, Michelle M. J., Abozaid, Yasir J., Bos, Daniel, Darwish Murad, Sarwa, de Knegt, Robert J., Ikram, M. Arfan, Pan, Qiuwei, Ghanbari, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Circulating Mrnas as Markers for Fatty Liver Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839694/
https://www.ncbi.nlm.nih.gov/pubmed/33244812
http://dx.doi.org/10.1111/apt.16177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839694/
https://www.ncbi.nlm.nih.gov/pubmed/33244812
http://dx.doi.org/10.1111/apt.16177

Ejemplares similares